CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 131399-131701 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T53258","span":{"begin":0,"end":302},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Taken together, our results indicate that the inhibition of microglia-mediated neuroinflammation through the glial inward rectifier potassium channel regulation is a prospective strategy for treating CNS demyelinating disorders such as MS that could be also combinable with inmmunomodulatory therapies."}

{"project":"Epistemic_Statements","denotations":[{"id":"T278","span":{"begin":0,"end":302},"obj":"Epistemic_statement"}],"text":"Taken together, our results indicate that the inhibition of microglia-mediated neuroinflammation through the glial inward rectifier potassium channel regulation is a prospective strategy for treating CNS demyelinating disorders such as MS that could be also combinable with inmmunomodulatory therapies."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T221","span":{"begin":0,"end":302},"obj":"Sentence"}],"text":"Taken together, our results indicate that the inhibition of microglia-mediated neuroinflammation through the glial inward rectifier potassium channel regulation is a prospective strategy for treating CNS demyelinating disorders such as MS that could be also combinable with inmmunomodulatory therapies."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T12288","span":{"begin":200,"end":217},"obj":"Phenotype"}],"attributes":[{"id":"A74821","pred":"hp_id","subj":"T12288","obj":"http://purl.obolibrary.org/obo/HP_0007305"}],"text":"Taken together, our results indicate that the inhibition of microglia-mediated neuroinflammation through the glial inward rectifier potassium channel regulation is a prospective strategy for treating CNS demyelinating disorders such as MS that could be also combinable with inmmunomodulatory therapies."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T524","span":{"begin":200,"end":203},"obj":"Body_part"},{"id":"T525","span":{"begin":236,"end":238},"obj":"Body_part"}],"attributes":[{"id":"A524","pred":"uberon_id","subj":"T524","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"A525","pred":"uberon_id","subj":"T525","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"Taken together, our results indicate that the inhibition of microglia-mediated neuroinflammation through the glial inward rectifier potassium channel regulation is a prospective strategy for treating CNS demyelinating disorders such as MS that could be also combinable with inmmunomodulatory therapies."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2479","span":{"begin":79,"end":96},"obj":"Disease"},{"id":"T38855","span":{"begin":204,"end":227},"obj":"Disease"},{"id":"T30359","span":{"begin":236,"end":238},"obj":"Disease"},{"id":"T51151","span":{"begin":79,"end":96},"obj":"Disease"},{"id":"T35640","span":{"begin":204,"end":227},"obj":"Disease"},{"id":"T79897","span":{"begin":236,"end":238},"obj":"Disease"}],"attributes":[{"id":"A10412","pred":"mondo_id","subj":"T2479","obj":"http://purl.obolibrary.org/obo/MONDO_0004466"},{"id":"A61483","pred":"mondo_id","subj":"T38855","obj":"http://purl.obolibrary.org/obo/MONDO_0002562"},{"id":"A82312","pred":"mondo_id","subj":"T30359","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A42354","pred":"mondo_id","subj":"T51151","obj":"http://purl.obolibrary.org/obo/MONDO_0004466"},{"id":"A94294","pred":"mondo_id","subj":"T35640","obj":"http://purl.obolibrary.org/obo/MONDO_0002562"},{"id":"A6843","pred":"mondo_id","subj":"T79897","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"Taken together, our results indicate that the inhibition of microglia-mediated neuroinflammation through the glial inward rectifier potassium channel regulation is a prospective strategy for treating CNS demyelinating disorders such as MS that could be also combinable with inmmunomodulatory therapies."}